Advertisement · 728 × 90
#
Hashtag
#Clariti
Advertisement · 728 × 90
Preview
CLARiTI Research Portfolio Welcome to the website for CLARiTI's research portfolio projects, including our new TDP43 Summit. This page features information on events and initiatives from the CLARiTI team at University of Wiscon...

📣Call for Abstracts: 2026 TDP43 Summit
Researchers are invited to submit abstracts featuring new and emerging data on #TDP43.
🔗uwmadison.co1.qualtrics.com/jfe/form/SV_06NGAuRlTgGr...

Learn more: sites.google.com/wisc.edu/cla...

RSVP: uwmadison.co1.qualtrics.com/jfe/form/SV_...

#CLARiTI

0 0 0 0

Additional $$$ Raises: #NiloTherapeutics $101M Series A; #Waat €100M; #Inspiren $100M Series B; #Einride $100M Series D; #Supabase $100M Series E

Acquisitions: #AimmerBiomet > #Monogram; #Coupe > #Scoutbee; #Clariti > #CivCheck; #Helsing > #BlueOcean; #Hyperproof > #Expent.ai

1 0 0 0
Preview
2025 Summit Advancing TDP43 Biomarkers: From Discovery to Application | Alzheimer's Disease Research Center RSVP today to join Drs. Henrik Zetterberg, Hartmuth Kolb and Sterling Johnson for the 2025 Summit Advancing TDP43 Biomarkers: From Discovery to Application, hosted by the University of Wisconsin–Madis...

Join @uwmadison.bsky.social and #CLARiTI for "Advancing TDP-43 Biomarkers: From Discovery to Application," a virtual summit exploring cutting-edge biomarker research.
📅 June 12
✅ RSVP at go.wisc.edu/92qiel to gain insights from top researchers shaping the future of neurodegenerative disease research

4 3 0 0
Preview
The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI) The presence of multiple pathologies is the largest predictor of dementia. A major gap in the field is the in vivo detection of mixed pathologies and their antecedents. The Alzheimer's Disease Resea.....

🧠 📷 We are excited to support the #CLARiTI initiative which will improve detection and understanding of mixed pathologies in Alzheimer's disease and related dementias (AD/ADRD).

Learn more about CLARiTI in @alzdemjournals.bsky.social
: alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

8 3 0 0
Preview
Immunovia's Achievements in 2024 and Vision for 2025: A Year-End Overview Immunovia's CEO Jeff Borcherding reviews the significant accomplishments of 2024 and outlines exciting prospects for 2025 as they transition to commercialization.

Immunovia's Achievements in 2024 and Vision for 2025: A Year-End Overview #Sweden #Immunovia #Lund #pancreatic_cancer #CLARITI

0 0 0 0